Nanjing Cuccess Pharmaceutiacal Co., Ltd is an enterprise of drug production and management that combines science, technology and trade in a functional entity, and it was established on March 9, 1992. The registered capital at present is 30 million Yuan and the total assets amounts to 157 million Yuan. Our enterprise mainly focuses on the production, marketing, consultation and services about medical care on various kinds of Chinese and western medicines. Cuccess is a holding subsidiary of Nanjing Xingang High-Tech Co., Ltd (stocks code: 600064).
The business activities and the profits of the company have steadily increased for ten years since 1998, and the company has established a good branding image in the market and become a well-known enterprise for drug production and management.
The production base of the company locates at the economic and technological development zone of Nanjing, and it has workshop of oral solid preparations, workshop of penicillin oral solid preparation, workshop of common injection preparations, workshop of drugs for external use, workshop of anti-tumor crude drugs and preparations and workshop of peptide drugs and other workshops.
Cuccess Pharmaceutiacal Co., Ltd mainly focuses on the researches and development of products for pediatrics, cardiovascular and cerebrovascular department, tumor department, infection department, digestion department, department of dermatology, department of gynecology and others. It exhibits good developing momentum after hard-work for more than ten years, and the average net assets income rate reaches more than 20% in the recent three years.
The marketing for the products spreads all over our country and the marketing income increases year by year. Among them the main product, a cold-fighting drug for children, Chengongzaixin obtains a widespread recognition among the clinical doctors and the consumers for its unique therapeutic effects and good services as the first cold-fighting drug for children in our country. Antitussive drug for eliminating phlegm in children,
Huafen, has a scientific prescription without addictive ingredients, which is a safe drug with immediate effect. Kengqiang is a compound preparation of amoxicillin potassium clavulanate (7:1) that firstly went on sale in 2001 by the company. It has exact therapeutic effects and low side effects. “Zaijia” is a new forth-group drug of national grade, and it is the first extended action tablet of isosorbide mononitrate that was approved by Ministry of Public Health in our country. It is specially used for the prevention and treatment of coronary artery disease and heart-stroke, and it is commented as the high-technological product of Jiangsu
province and new national key product. The on-sale of “Weilixian” and a series of new products have gained good market feedback. A lot of promising perspective products are under research and development.
The company undertakes the belief of “making more people live better”. It innovates actively and makes efforts to develop, and it will provide more superior products and services.
